Inventor
PARK HAENGSOON
US14 patents
⚠️ This page may combine multiple inventors who share the name “PARK HAENGSOON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARMACOPEIA DRUG DISCOVERY
6 patentsUS7161003B1Jan 9, 2007
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY32 citations91
US7119200B2Oct 10, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY45 citations91
US7078525B2Jul 18, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY15 citations84
US7084271B2Aug 1, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY9 citations73
US7074924B2Jul 11, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY2 citations62
US7067661B2Jun 27, 2006
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
PHARMACOPEIA DRUG DISCOVERY5 citations61
SCHERING CORP
6 patentsUS7468372B2Dec 23, 2008
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP7 citations72
US7309705B2Dec 18, 2007
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP2 citations62
US7470695B2Dec 30, 2008
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations52
US7807683B2Oct 5, 2010
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations51
US7514442B2Apr 7, 2009
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP1 citations51
US7511049B2Mar 31, 2009
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP0 citations51